Seek­er Bi­o­log­ics, a 5AM Ven­tures biotech led by ex-Trans­late Bio pres­i­dent, shuts down

Seek­er Bi­o­log­ics, a Boston-based biotech start­up formed out of 5AM Ven­tures to make new bi­o­log­ics, has shut down.

Seek­er set out to make new med­i­cines for au­toim­mune, al­ler­gic and in­flam­ma­to­ry dis­eases and had se­cured a Se­ries A fi­nanc­ing, ac­cord­ing to job post­ings and pro­file de­scrip­tions on LinkedIn.

“It can be chal­leng­ing to wit­ness a tal­ent­ed team ded­i­cat­ed to dis­cov­er­ing new med­i­cines fall short of their am­bi­tious goals in a de­mand­ing mar­ket. How­ev­er, sci­ence doesn’t al­ways take us in the di­rec­tion we ex­pect, nor does it ad­here to our time­line,” Jar­rat Jor­dan, VP and head of bi­ol­o­gy at Seek­er, wrote in a LinkedIn post on Thurs­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER